Gender-differential effects on blood glucose levels between acarbose and metformin in Chinese patients with newly diagnosed type 2 diabetes: a sub-analysis of the MARCH trial.


Journal

Endocrine journal
ISSN: 1348-4540
Titre abrégé: Endocr J
Pays: Japan
ID NLM: 9313485

Informations de publication

Date de publication:
28 Jan 2021
Historique:
pubmed: 11 9 2020
medline: 18 11 2021
entrez: 10 9 2020
Statut: ppublish

Résumé

Using the data from the trial of Metformin and AcaRbose in Chinese as the initial Hypoglycemic treatment (MARCH), this study was performed to compare the differential effects of acarbose and metformin on glucose metabolism after stratification by gender. Six hundred and forty patients who had finished the whole 48-week follow-up were included. The reduction of haemoglobin A1c (HbA

Identifiants

pubmed: 32908086
doi: 10.1507/endocrj.EJ20-0006
doi:

Substances chimiques

Blood Glucose 0
Metformin 9100L32L2N
Acarbose T58MSI464G

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

69-79

Auteurs

Jianxin Li (J)

Department of Endocrinology and Metabolism, Institute of Endocrinology, Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Affiliated Hospital of China Medical University, Shenyang, 110001, China.
The Third People's Hospital of Dalian (Dalian Third People's Hospital Affiliated to Dalian Medical University), Dalian, 116000, China.

Jing Li (J)

Department of Endocrinology and Metabolism, Institute of Endocrinology, Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Affiliated Hospital of China Medical University, Shenyang, 110001, China.

Zhongyan Shan (Z)

Department of Endocrinology and Metabolism, Institute of Endocrinology, Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Affiliated Hospital of China Medical University, Shenyang, 110001, China.

Wenying Yang (W)

China-Japan Friendship Hospital, Beijing, 100029, China.

Jie Liu (J)

Shanxi Province People's Hospital, Taiyuan, 030032, China.

Haoming Tian (H)

West China Hospital, Sichuan University, Chengdu, 610211, China.

Zhiguang Zhou (Z)

Xiangya Second Hospital of Central South University, Changsha, 210009, China.

Qiuhe Ji (Q)

Xijing Hospital, Fourth Military Medical University, Xi'an, 400039, China.

Jianping Weng (J)

The Third Affiliated Hospital of Sun Yatsen University, Guangzhou, 510630, China.

Weiping Jia (W)

Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, 201303, China.

Juming Lu (J)

Chinese People's Liberation Army General Hospital, Beijing, 100039, China.

Jing Liu (J)

Gansu Provincial Hospital, Lanzhou, 730000, China.

Yuan Xu (Y)

Beijing Chao Yang Hospital, Beijing, 100020, China.

Zhaojun Yang (Z)

China-Japan Friendship Hospital, Beijing, 100029, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH